Flogaduo Extended-Release Tablets 5/500 mg
Dapagliflozin citric acid 7.35mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
MFDS item code 202204065 · Approved 2022.11.10
Improves glycemic control in adults with type 2 diabetes mellitus
This medication is used to improve blood glucose control in adult patients with type 2 diabetes when combined with dietary and exercise therapy. It is particularly effective for patients whose blood glucose is not adequately controlled by using dapagliflozin in conjunction with metformin. Furthermore, in the case of patients with cardiovascular disease or risk factors, it is important to reference expert guidelines regarding the impact of dapagliflozin on cardiovascular events and use it safely. This medication enhances blood glucose control and assists in managing type 2 diabetes.
The dose of this medicine should be individualized based on the patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended dose of dapagliflozin 10mg and extended-release metformin 2000mg. This medicine is generally administered once daily with the evening meal. The maximum dose of this medicine is dapagliflozin 10mg/extended-release metformin 2000mg once daily, administered as 2 tablets of 5mg/1000mg. Patients who have not previously received antidiabetic drug therapy and whose blood glucose is not adequately controlled with monotherapy: When used as initial therapy in patients who have not previously received antidiabetic drug therapy, the recommended starting dose of this medicine is 1 tablet of 5mg/500mg or 10mg/500mg once daily. Titrate the dose gradually to reduce the gastrointestinal adverse effects of metformin. For patients receiving metformin, the recommended dose of dapagliflozin is 10mg once daily, and the dose of this medicine should provide the dose of metformin the patient was taking or an appropriately equivalent therapeutic dose. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted as appropriate. For patients switching from combination therapy with dapagliflozin and metformin to this medicine, treatment may be initiated at the doses of dapagliflozin and metformin they were previously receiving. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted as appropriate. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. The safety and efficacy of this medicine have not been specifically evaluated in patients switching from other antihyperglycemic agents. Since any change may cause changes in blood glucose control, changes in the treatment of patients with type 2 diabetes should be made under close monitoring. This medicine must be swallowed whole and must never be crushed, cut, or chewed. Occasionally, the inactive ingredients of this medicine may be excreted in the stool as a soft, hydrated mass resembling a tablet. Renal impairment No dose adjustment is necessary in patients with mild renal impairment. For patients with an estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73 m2 or more and less than 60 mL/min/1.73 m2 who have no other condition that may increase the risk of lactic acidosis, the starting dose of metformin hydrochloride, a component of this medicine, is 500mg once daily, and the maximum daily dose is 1000mg. Administration of this medicine is not recommended in patients with an eGFR of less than 45 mL/min/1.73m2. If the estimated glomerular filtration rate (eGFR) falls below 45 mL/min/1.73m2, this medicine should be discontinued immediately. Renal function should be assessed every 3~6 months. Elderly patients Because metformin is excreted by the kidneys and renal function is more likely to decline in elderly patients, this medicine should be used with caution as age increases (see Precautions for Use, 9. Administration to Elderly Patients, Patient section).
This medication is used for the treatment of diabetes and helps in controlling blood glucose levels. Caution is needed as a rare side effect called severe lactic acidosis may occur while taking this medication. Lactic acidosis can lead to dangerous conditions due to excessive accumulation of lactic acid in the body. Furthermore, when taken with insulin or sulfonylureas, there is a risk of hypoglycemia, so careful monitoring of blood glucose levels is necessary. Patients with certain health conditions such as impaired kidney function, dehydration, severe infections, or weakened heart function should not take this medication. Prior to and following surgical procedures or tests using iodine-based contrast agents, this medication should be temporarily discontinued, and it should be resumed only after confirming normal kidney function. Women who are pregnant or breastfeeding should not use this medication, and safety and efficacy have not been established for children. Caution is warranted for patients at risk of decreased fluid volume or hypotension, especially in elderly patients or those with reduced kidney function, who should have their kidney function monitored regularly. During treatment, genital or urinary infections may occur, so immediate consultation with healthcare professionals is recommended if related symptoms appear. This medication can lower vitamin B12 levels, so regular checks of vitamin B12 levels are advised for prolonged usage. Excessive alcohol consumption can increase the risk of side effects of this medication, so it should be avoided. Due to the risk of hypoglycemia, any symptoms of hypoglycemia (such as dizziness, cold sweat, severe fatigue, etc.) should be addressed immediately, and dosage adjustments may be necessary when taken with insulin or other hypoglycemic agents. Symptoms of dehydration or hypotension may occur while taking this medication, so adequate fluid intake and blood pressure management are important. This medication does not significantly affect driving or the operation of machinery, but caution should be exercised due to possible dizziness. It is crucial to adhere to the prescribed methods and dosages while taking the medication and to receive regular check-ups as directed by a healthcare provider. Keep out of the reach of children and store in the original container to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air or moisture, and it is best to keep it at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the efficacy of the medication over time.
Orange, biconvex, egg-shaped film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Dapagliflozin citric acid 7.35mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationDapagliflozin citric acid 14.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
CombinationDapagliflozin citric acid 7.35mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
Dapagliflozin citric acid 14.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Poonglim Pharmaceutical Co., Ltd.
Dapagliflozin citric acid 7.35mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Punglim Muhak Co., Ltd.
CombinationDapagliflozin citric acid 14.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.
Dapagliflozin citric acid 7.35mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.
CombinationDapagliflozin citric acid 14.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
KS Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.